This invention relates to an in-vivo diagnostic method based on near infrared
radiation (NIR radiation) that uses water-soluble dyes and their biomolecule adducts,
each having specific photophysical and pharmaco-chemical properties, as a contrast
medium for fluorescence and transillumination diagnostics in the NIR range, to
new dyes and pharmaceuticals containing such dyes.
